Prognostic role and clinicopathological features of SMAD4 gene mutation in pancreatic cancer: a systematic review and meta-analysis

Tânia Rodrigues, Joana Albuquerque, Joana Cardoso, Ivo Sousa-Ferreira, João Paulo Martins, José Luís Passos Coelho

Open source

DOI
10.1016/j.ctarc.2025.101091
Published
2026
Container
Cancer Treatment and Research Communications
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ctarc.2025.101091,
  title = {Prognostic role and clinicopathological features of SMAD4 gene mutation in pancreatic cancer: a systematic review and meta-analysis},
  author = {Tânia Rodrigues and Joana Albuquerque and Joana Cardoso and Ivo Sousa-Ferreira and João Paulo Martins and José Luís Passos Coelho},
  year = {2026},
  journal = {Cancer Treatment and Research Communications},
  doi = {10.1016/j.ctarc.2025.101091},
  url = {https://doi.org/10.1016/j.ctarc.2025.101091}
}

RIS

TY  - JOUR
TI  - Prognostic role and clinicopathological features of SMAD4 gene mutation in pancreatic cancer: a systematic review and meta-analysis
AU  - Tânia Rodrigues
AU  - Joana Albuquerque
AU  - Joana Cardoso
AU  - Ivo Sousa-Ferreira
AU  - João Paulo Martins
AU  - José Luís Passos Coelho
PY  - 2026
JO  - Cancer Treatment and Research Communications
DO  - 10.1016/j.ctarc.2025.101091
UR  - https://doi.org/10.1016/j.ctarc.2025.101091
ER  - 

APA

Rodrigues, T., Albuquerque, J., Cardoso, J., Sousa-Ferreira, I., Martins, J. P., & Coelho, J. L. P. (2026). Prognostic role and clinicopathological features of SMAD4 gene mutation in pancreatic cancer: a systematic review and meta-analysis. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2025.101091

Source records